Found: 31
Select item for more details and to access through your institution.
Association of Biological Age with Tumor Microenvironment in Patients with Esophageal Adenocarcinoma.
- Published in:
- Gerontology, 2024, v. 70, n. 4, p. 337, doi. 10.1159/000536471
- By:
- Publication type:
- Article
Gastrointestinal Symptoms After Resection of Esophagogastric Cancer: A Longitudinal Study on Their Incidence and Impact on Patient-Reported Outcomes.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 13, p. 8203, doi. 10.1245/s10434-023-13952-z
- By:
- Publication type:
- Article
ASO Visual Abstract: Gastrointestinal Symptoms After Resection of Esophagogastric Cancer: A Longitudinal Study on Their Incidence and Impact on Patient-Reported Outcomes.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0294147
- By:
- Publication type:
- Article
Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 10, p. e2339116, doi. 10.1001/jamanetworkopen.2023.39116
- By:
- Publication type:
- Article
Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 9, p. 1, doi. 10.1007/s00520-023-07963-5
- By:
- Publication type:
- Article
Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population‐based study.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 10, p. 2043, doi. 10.1002/ijc.34422
- By:
- Publication type:
- Article
Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development.
- Published in:
- Journal of Gastroenterology, 2023, v. 58, n. 1, p. 25, doi. 10.1007/s00535-022-01928-x
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1944, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221109196
- By:
- Publication type:
- Article
<sup>89</sup>Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263470
- By:
- Publication type:
- Article
Geriatric assessment and treatment outcomes in a Dutch cohort of older patients with potentially curable esophageal cancer.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 4, p. 459, doi. 10.1080/0284186X.2022.2036366
- By:
- Publication type:
- Article
Neoadjuvant chemoradiotherapy followed by resection for esophageal cancer: clinical outcomes with the 'CROSS-regimen' in daily practice.
- Published in:
- Diseases of the Esophagus, 2022, v. 35, n. 4, p. 1, doi. 10.1093/dote/doab068
- By:
- Publication type:
- Article
A population-based study in synchronous versus metachronous metastatic esophagogastric adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221085557
- By:
- Publication type:
- Article
Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3147, doi. 10.3390/ijms23063147
- By:
- Publication type:
- Article
Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6366, doi. 10.3390/cancers13246366
- By:
- Publication type:
- Article
Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 5205, doi. 10.2147/OTT.S322276
- By:
- Publication type:
- Article
Design and rationale of a routine clinical care pathway and prospective cohort study in older patients needing intensive treatment.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 4, p. 579, doi. 10.1007/s10120-020-01039-7
- By:
- Publication type:
- Article
Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence
- Published in:
- Head & Neck, 2020, v. 42, n. 5, p. 828, doi. 10.1002/hed.26053
- By:
- Publication type:
- Article
Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 7, p. 1889, doi. 10.1002/ijc.32580
- By:
- Publication type:
- Article
Geriatric assessment and 1‐year mortality in older patients with cancer in the head and neck region: A cohort study.
- Published in:
- Head & Neck, 2019, v. 41, n. 8, p. 2477, doi. 10.1002/hed.25714
- By:
- Publication type:
- Article
PEG tube dependency after prophylactic placement in 209 head and neck cancer patients treated with chemoradiotherapy or radiation with cetuximab.
- Published in:
- Clinical Otolaryngology, 2019, v. 44, n. 2, p. 172, doi. 10.1111/coa.13282
- By:
- Publication type:
- Article
Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.
- Published in:
- Head & Neck, 2018, v. 40, n. 3, p. 605, doi. 10.1002/hed.25035
- By:
- Publication type:
- Article
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function.
- Published in:
- 2014
- By:
- Publication type:
- Report
Severe colitis while responding to ipilimumab in metastatic melanoma.
- Published in:
- 2012
- By:
- Publication type:
- Letter
The fate of camptothecin glycoconjugate: report of a clinical hold during a phase II study of BAY 56-3722 (formerly BAY 38-3441), in patients with recurrent or metastatic colorectal cancer resistant/refractory to irinotecan.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1208, doi. 10.1007/s10637-011-9679-4
- By:
- Publication type:
- Article